CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...

A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared ...

Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...

Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...

The weight loss drug Wegovy may do more than help people lose weight New trial results show the weight-loss medication Wegovy can also cut heart attack and stroke risks, according to the drug's maker.

"Even if I didn't lose another pound, I'd take this drug as long as I could," Halstead said. "But at $700 a month, that's not going to happen." Even as weight loss drugs such as Wegovy and ...

Novo Nordisk, which funded both recent trials, sells semaglutide for diabetes under the name Ozempic and for weight loss, as Wegovy. Both drugs have been in short supply for most of the last two ...

Diabetes drugs Wegovy and Ozempic, which have gained popularity as weight-loss drugs, face major supply issues, drugmaker Novo Nordisk admitted, as the company struggles with surging demand.